市場調查報告書
商品編碼
1071778
表達載體的全球市場規模:主型式,各用途,各終端用戶,不同地區的預測(2022年~2028年)Global Expression Vectors Market Size study, By Host Type, By Application, By End User, and Regional Forecasts 2022-2028 |
全球表達載體的市場規模在2021年估算為約3億3,454萬美金,在2022年~2028年的預測期間內預計將以5.5%以上健全的成長率成長。
本報告提供全球表達載體市場相關調查分析,提供市場趨勢,產業分析,COVID-19影響,各市場區隔·各地區的市場分析,企業簡介等資訊。
Global Expression Vectors Market is valued approximately USD 334.54 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2022-2028.
An expression vector is also generally called as an expression construct that is a virus or plasmid planned for gene expression in cells. This vector is mainly used to introduce a particular gene into a target cell and can seize the cell's mechanism for protein synthesis to create the protein encoded by the gene. The growing demand for protein-based drugs, rising prevalence of lifestyle diseases, infectious diseases, and genetic disorders, technological developments, coupled with the increased funding for protein research are the primary factors that are fostering market growth across the globe. For instance, as per the national cancer institute, cancer is the leading cause of death around the world. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths occurred globally. Also, by 2040, the number of new cancer cases per year is likely to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Therefore, rising incidences of lifestyle diseases like cancer, cardiovascular diseases, diabetes, and many others are anticipated to bolster the demand for the expression vector, which, in turn, impels market growth. However, increasing competition among the market players and the high cost of protein therapy impede the growth of the market over the forecast period of 2022-2028. Also, rising investments in the R&D activities and development of the emerging market are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the Global Expression Vectors Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to rising investment by the public and private companies in biology research and emergence of the novel technologies in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing awareness for the availability of biologics and development of the healthcare infrastructure, and growth of the emerging economies such as India and China would create lucrative growth prospects for the Expression Vectors market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Promega Corporation
Sigma-Aldrich Corporation
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
New England Biolabs Inc.
Merck Millipore
QIAGEN N.V.
Clontech Laboratories, Inc.
ATUM
GenScript USA Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Host Type
Bacterial Expression Vectors
Mammalian Expression Vectors
Insect Expression Vectors
Yeast Expression Vectors
Other Expression Vectors
By Application
Therapeutic Applications
Research Applications
Industrial Applications
By End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
Academic Research Institutes
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019. 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Expression Vectors Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures